Gavin Newsom recently signed a bill to fast-track the study of psychedelic drugs that hold enormous potential to treat post-traumatic stress disorder and depression, according to a coalition of ...

An experimental drug reverses PTSD-like symptoms in mice. The corresponding study was published in Signal Transduction and Targeted Therapy and may pave the way for a new treatment for PTSD. “This ...

Moment of Clarity in Long Beach has released a new resource titled “Transcranial Magnetic Stimulation (TMS) for PTSD“, now ...

Physicians are exploring psychedelic-assisted therapy for patients — but federal law still forbids it. A healthcare attorney ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

The FDA has issued a CRL to Otsuka and Lundbeck regarding the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD.

Lawmakers set aside the money in the state budget to study ibogaine, which may help treat PTSD and other ailments.

Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression ...

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia. Dementia is a memory problem that affects a person's ability to carry out ...

SARASOTA, FL, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, ...

SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, ...